PET/CT and Oncology Imaging
Research involving cancer detection, staging, treatment response and clinically important incidental findings.
Publications & research background
William Makis Nuclear Medicine Research
Selected publication records covering PET/CT imaging, oncology, neuroendocrine tumors and targeted radionuclide therapy. Study design and publication source are shown to help readers evaluate the evidence.
Research themes
Imaging and therapeutic nuclear medicine
Targeted Radionuclide Therapy
Clinical reports involving 177Lu-DOTATATE peptide receptor radionuclide therapy and 131I-MIBG.
Neuroendocrine Tumors
Uncommon metastatic patterns, imaging findings, treatment response and safety considerations.
Selected PubMed records
Publication examples
Clinical research2015
Role for 11C-Choline PET in Active Surveillance of Prostate Cancer
Serial PET imaging alongside biopsy and clinical monitoring in patients on active surveillance.
View on PubMed →Retrospective study2017
Thyroid Incidentalomas on 18F-FDG PET/CT
Frequency, malignancy risk and interpretation of unexpected focal thyroid uptake in oncology imaging.
View on PubMed →Case series2015
Cardiac Metastases of Neuroendocrine Tumors
Cardiac metastatic disease identified among patients treated with targeted radionuclide therapies.
View on PubMed →Safety case series2015
Challenges of Treating Paraganglioma With 177Lu-DOTATATE
Catecholamine crises, tumor lysis syndrome and modified safety considerations during radionuclide therapy.
View on PubMed →Related resources